- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Loxo Oncology, Inc.
Total 1004 results
-
Eli Lilly and CompanyLoxo Oncology, Inc.Not yet recruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.Recruiting
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Leukemia, B-cell | Small Lymphocytic Lymphoma | Leukemia, LymphocyticUnited States, Spain, Canada, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, Italy, Czechia, Hungary, China, Israel, Belgium, France, Poland, Turkey, Austria, United Kingdom, Germany, Argentina, Brazil, Chile
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada, United States, Korea, Republic of, Australia, China, Taiwan, Spain, Italy, United Kingdom, Japan, Ireland, Denmark, Hungary, Poland, Czechia, France, Israel, Singapore, Belgium, Sweden, Germany, Switzerland
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingCarcinoma, Non-Small-Cell LungUnited States, Denmark, Taiwan, China, Canada, Spain, Germany, Japan, United Kingdom, Brazil, India, Korea, Republic of, Australia, Italy, Norway, Israel, Greece, Turkey, Netherlands, Austria, Belgium, Hong Kong, Poland, Puerto Rico, Cz... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, United States, Australia, Korea, Republic of, United Kingdom, Japan, Spain, Belgium, Italy, Hungary, Israel, Canada, Czechia, Taiwan, Russian Federation, Germany, Austria, Croatia, France, Ireland, Poland, Singapore, Switzerland and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Spain, Czechia, Taiwan, Italy, Japan, New Zealand, Poland, Hungary, United States, United Kingdom, Australia, Romania, Portugal, Korea, Republic of, Russian Federation, Austria, Brazil, Bulgaria, France, Ireland
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingCarcinoma, Non-Small-Cell Lung | Thyroid NeoplasmsUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.No longer availableCarcinoma, Non-Small-Cell Lung | Thyroid Neoplasms
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Leukemia, Lymphoid | Leukemia, Lymphocytic, Chronic, B-CellChina
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted
-
Loxo Oncology, Inc.CompletedHealthy VolunteersUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Italy, Belgium, Australia, United Kingdom, Canada, Singapore
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingB-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingNon-Small Cell Lung CancerChina, Spain, Canada, Israel, Italy, Japan, Korea, Republic of, Taiwan, Australia, Poland, Brazil, Turkey, Belgium, Singapore, Czechia, Romania, Germany, Russian Federation, Greece, Netherlands, Argentina, France, Hong Kong, Mexico, Ukr... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasms (MPNs)United States, Spain, Korea, Republic of, France, Taiwan, Australia, Belgium, Singapore, Israel, Canada, Germany, Finland
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Terminated
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompletedHealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingCervical Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Renal Pelvis Cancer | Urinary Bladder Neoplasm | Recurrent...United States
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Neoplasm MetastasisUnited States, Taiwan, Japan, Australia, United Kingdom, Spain, China, France, Germany, Austria, Korea, Republic of, Hungary, Switzerland, Turkey, Mexico, Czechia, Norway, Italy, Portugal, Netherlands, India, Belgium, Romania, Canada, D... and more
-
Eli Lilly and CompanyLoxo Oncology, Inc.Not yet recruiting
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingLymphoma, Mantle-CellCanada, United States, China, Australia, Spain, Taiwan, Japan, Belgium, Germany, Denmark, Hungary, Italy, Brazil, Israel, Austria, Czechia, France, Ireland, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Russian Federation and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingSoft Tissue Sarcoma | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Infantile Fibrosarcoma | Infantile MyofibromatosisUnited States, Australia, Japan, Canada, Germany, Korea, Republic of, France, Spain, United Kingdom, Denmark, Italy
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingNon-Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Any Solid TumorUnited States, Japan, Taiwan, Australia, Korea, Republic of, Israel, Spain, Switzerland, Singapore, France, Canada, Italy, Germany, United Kingdom, Hong Kong, Denmark
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHepatic Insufficiency | HealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Renal InsufficiencyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States